Keyphrases
Apparent Diffusion Coefficient
28%
Baby Born
38%
Brain Development
9%
Brain Microstructure
28%
Brain Size
33%
Brain Structure
19%
Brain Vessels
9%
Chronic Lung Disease
9%
Cranial Ultrasound
14%
Derangement
9%
Developmental Disabilities
9%
Diffusion Coefficient Measurement
9%
Disability
9%
Early Development
9%
Expected Date of Delivery
19%
Extreme Prematurity
9%
Extremely Premature
28%
Fetal Brain
9%
Free Thyroxine
9%
Gestational Age
47%
Head Circumference
14%
High Risk
9%
Hormone Concentration
14%
HPA Axis
9%
Hypothalamic-pituitary Axis
9%
Hypothyroxinemia
19%
Internal Capsule
9%
Levothyroxine
47%
Magnetic Resonance Findings
28%
Major Risk Factors
9%
Multi-centered
9%
Myelination
19%
Neurodevelopmental
28%
Neuroimaging Techniques
9%
Oxygen Demand
9%
Placebo
19%
Prematurity
9%
Preterm Infants
57%
Randomized Controlled Trial
61%
Randomized Placebo-controlled Trial
28%
Sensitive Windows
9%
Somatic Growth
14%
Subarachnoid Space
23%
Term Equivalence
9%
Thyroid Function
9%
Thyroid Hormone Status
9%
Thyroid Hormone Supplementation
19%
Thyroid Hormones
23%
Thyroid Supplementation
9%
Thyroid Volume
9%
Thyroxine
61%
Thyroxine Supplementation
47%
Tractography
9%
Ventilation Rate
9%
Vessel Morphology
19%
White Matter Development
9%
White Matter Integrity
9%
Medicine and Dentistry
Adverse Event
9%
Artificial Respiration
7%
Body Growth
11%
Brain Development
7%
Chronic Lung Disease
7%
Corpus Callosum
17%
Developmental Disorder
7%
Diffusion Tensor Imaging
17%
Fractional Anisotropy
11%
Gestational Age
42%
Hypothalamic-Pituitary-Adrenal Axis
7%
Hypothalamus Hypophysis System
7%
Hypothyroxinemia
14%
Internal Capsule
5%
Levothyroxine
41%
Magnetic Resonance Imaging of Brain
11%
Myelination
14%
Neonatal Infant
28%
Occipital Lobe
5%
Oxygen Consumption
7%
Placebo
35%
Prematurity
28%
Primary Outcome
7%
Randomized Controlled Trial
61%
Subarachnoid Space
21%
Supplementation
71%
Thyroid Function
7%
Thyroid Hormone
39%
Thyroxine
100%
Tractography
5%